One of the largest pharmaceutical companies in Europe, STADA, has signed an exclusive supply agreement with cannabis company MediPharm Labs.
According to information procured exclusively, MediPharm Labs will provide the pharmaceutical company, which reported more than $3 billion in revenue in 2019, with medical cannabis products for its distribution in Germany, as well as manufacturing, logistics, and regulatory support,
STADA will be responsible for commercializing the products and providing medical education through its pharmaceutically trained field team.
Shipments are expected to begin early next year. The products may be sold in other E.U. countries beyond Germany in the future, a MediPharm representative said.